| Patents for A61P 39 - General protective or antinoxious agents (19,019) |
|---|
| 05/05/1993 | CN1020458C Conjugates of superoxide dismutase couples tod high molecular weight polyalkylene glycols |
| 05/04/1993 | US5208324 Paramagnetic compounds |
| 04/29/1993 | WO1993008274A1 Use of thiol redox proteins for reducing disulfide bonds |
| 04/29/1993 | CA2121137A1 Use of thiol redox proteins for reducing disulfide bonds |
| 04/28/1993 | EP0538422A1 New use of diphenylbutylpiperazinecarboxamides in the treatment of substance disorders |
| 04/28/1993 | CN1071416A N-alkyl-3-phenyl-3-(2-alkylthiophe-noxy) propylamines |
| 04/27/1993 | US5206008 Using androstene(diol or triol) |
| 04/21/1993 | EP0537915A1 N-alkyl-3-phenyl-3-(2-alkylthiophenoxy)propylamines as norepinephrine inhibitors |
| 04/15/1993 | WO1993006868A1 Dendrimeric polychelants |
| 04/15/1993 | WO1992020328A3 Improvements in benzodiazepine treatment by cholinesterase inhibitors |
| 04/15/1993 | CA2120763A1 Dendrimeric polychelants |
| 04/14/1993 | EP0536295A1 Certain azacycloalkyl imidazopyrimidines; a new class of gaba brain receptor ligands |
| 04/01/1993 | WO1993006105A1 Substituted phenserines and phenylcarbamates of (-)-eseroline, (-)-n1-noreseroline, and (-)-n1-benzylnoreseroline; as specific inhibitors of acetylcholinesterase |
| 03/31/1993 | EP0534756A2 N-alkyl-3-phenyl-3-(2-halo-substituted phenoxy)propylamines as norepinephrine uptake inhibiteurs |
| 03/31/1993 | EP0533872A1 Use of apotransferrin which has accumulated zinc or copper ions to combat the toxic action of endotoxin |
| 03/28/1993 | CA2079162A1 N-alkyl-3-phenyl-3-(2-halo-substituted phenoxy) propylamines |
| 03/17/1993 | EP0532027A1 Cyclic nitrones, their preparation and pharmaceutical compositions containing them |
| 02/24/1993 | EP0528164A2 Use of xanthine derivatives for the manufacture of a medicament for the treatment of secondary nerve cell damages and function disorders after head-brain-traumata |
| 02/18/1993 | WO1993002693A2 Use of interleukin-10 analogs or antagonists to treat endotoxin- or superantigen induced toxicity |
| 02/18/1993 | WO1992019613A3 1,2-dithiole-3-thione derivative-based therapeutical compositions |
| 02/09/1993 | US5185368 Complex with trivalent metal ions; medical diagnosis and therapy |
| 02/04/1993 | WO1993002090A1 Manganese complexes of nitrogen-containing macrocyclic ligands effective as catalysts for dismutating superoxide |
| 02/04/1993 | WO1993001831A1 Induction of cytotoxic t-lymphocyte responses |
| 02/04/1993 | CA2113720A1 Induction of cytotoxic t-lymphocyte responses |
| 02/03/1993 | EP0349545B1 New cardiodilatin fragment, process for preparing same and use thereof |
| 01/21/1993 | WO1993001202A1 Treatment of chemotherapeutic agent and antiviral agent toxicity with acylated pyrimidine nucleosides |
| 01/20/1993 | EP0524161A1 Manganese complexes of nitrogen containing macrocyclic ligands effective as catalysts for dismutating superoxide |
| 12/23/1992 | EP0377613B1 Conjugates of superoxide dismutase |
| 12/15/1992 | US5171739 Treatment of endotoxin-associated shock and preventation thereof using a BPI protein |
| 12/10/1992 | WO1992021354A1 Methods and compositions based on inhibition of cell invasion and fibrosis by anionic polymers |
| 11/26/1992 | WO1992020328A2 Improvements in benzodiazepine treatment by cholinesterase inhibitors |
| 11/25/1992 | EP0515302A1 Treatment of fatigue syndrome with cholinesterase inhibitor |
| 11/19/1992 | EP0514023A1 Use of glycine/NMDA receptor ligands for the manufacture of a medicament for the treatment of drug dependence and withdrawal |
| 11/19/1992 | EP0513104A1 USE OF AN -g(a)-TOCOPHEROL PHOSPHATE OR A DERIVATIVE THEREOF FOR PREPARING COSMETIC, DERMATOLOGICAL OR PHARMACEUTICAL COMPOSITIONS, AND COMPOSITIONS THEREBY OBTAINED. |
| 11/12/1992 | WO1992019613A2 1,2-dithiole-3-thione derivative-based therapeutical compositions |
| 11/12/1992 | WO1992019280A1 Antivenom immunesera |
| 11/04/1992 | EP0511275A1 Chelating compounds |
| 10/27/1992 | CA2066834A1 Use of glycine/nmda receptor ligands for the treatment of drug dependence and withdrawal |
| 10/20/1992 | US5157140 Esters of myo-inositol phosphate |
| 10/20/1992 | CA1309046C Conjugates of superoxide dismutase coupled to high molecular weight polyalkylene glycols |
| 10/15/1992 | WO1992017186A1 Compounds that prevent endotoxin shock and method of using the compounds |
| 10/14/1992 | EP0508488A2 Use of inositol triphosphate for the treatment of diseases associated with metal intoxications |
| 10/07/1992 | EP0507348A2 Superoxide dismutase derivatives |
| 10/01/1992 | WO1992016227A1 Use of apotransferrin which has accumulated zinc or copper ions to combat the toxic action of endotoxin |
| 10/01/1992 | WO1992016211A1 New use of diphenylbutyl-piperazinecarboxamides in the treatment of substance disorders |
| 09/24/1992 | DE4109254A1 Verwendung von apotransferrin, welches zweiwertige kationen angelagert hat, zur bekaempfung der toxischen wirkung des endotoxins Use of apotransferrin that has bound divalent cations to combat the toxic effect of endotoxins |
| 09/22/1992 | WO1992016544A1 Novel derivative of caffeic acid, oraposide, cosmetic or pharmaceutical, particularly dermatological, composition containing it |
| 09/22/1992 | US5149879 Polysulfides compounds and lipid peroxidation inhibitor containing the polysulfide compounds as active ingredient |
| 09/22/1992 | US5149435 Molecular sieve arrangement and filtering method for removal of a selected constituent |
| 09/22/1992 | CA2102689A1 Novel caffeic acid derivative, oraposide, and cosmetic or pharmaceutic, especially dermatological, composition containing it |
| 09/17/1992 | WO1992015292A1 Therapeutic compositions to protect and resuscitate mammalian cells and methods for preparing and using same |
| 09/16/1992 | EP0503484A2 Monoclonal antibodies as antidotes |
| 08/25/1992 | US5141943 Water soluble uridine phosphorylase inhibitors, reducing toxicity and anemia of antiviral drugs |
| 08/25/1992 | CA1306746C Cyclic amino-thioacetal amides, a process for the preparation thereofand pharmaceutical compositions containing them |
| 08/20/1992 | WO1992014483A1 Production and use of butyrylcholinesterase |
| 08/12/1992 | EP0498718A1 Use of 4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydro-pyridine-derivatives as free radical scavengers |
| 08/11/1992 | CA1306258C Certain cycloalka-[b]-pyrazolo[3,4-d]-pyridin-3-one derivatives |
| 08/06/1992 | WO1992012716A1 Pharmaceutical composition containing granisetron and dexamethasone |
| 08/05/1992 | EP0497202A1 Polyamine thiols as radioprotective agents |
| 07/22/1992 | EP0495450A2 Polyamine phenols as radioprotective agents |
| 07/18/1992 | CA2059487A1 Polyamine phenols as radioprotective agents |
| 07/15/1992 | EP0494777A1 (S)-11-Hydroxy-10-methyl aporphine and pharmaceutical compositions containing it |
| 07/12/1992 | CA2059142A1 11-hydroxyaporphines and their biologically active salt forms as 5-ht1a inhibitors |
| 07/09/1992 | WO1992010995A1 Novel compositions |
| 07/09/1992 | CA2098730A1 Compositions |
| 07/08/1992 | EP0494057A1 Hydrolytic stabilizer for water soluble bis-quaternary pyridinium oximes |
| 06/24/1992 | EP0396617B1 Paramagnetic compounds |
| 06/22/1992 | WO1992011232A1 Chelating agents |
| 06/22/1992 | CA2098712A1 Chelating agents |
| 06/17/1992 | EP0490379A2 Diamino acid derivatives and pharmaceutical compositions |
| 06/14/1992 | CA2057601A1 Pharmaceutical use of diamino acid derivatives |
| 06/09/1992 | CA1303038C Diselenobis benzoic acid amides of primary heterocyclic amines, process for producing the same and pharmaceutical compounds comprisingthe same |
| 05/27/1992 | EP0486958A1 Physostigmine derivatives |
| 05/27/1992 | EP0486632A1 Anti-actinic agent. |
| 05/19/1992 | US5114966 2,3-dihydro-5-oxy-4,6,7-trimethylbenzofurans 2-(rs)-substituted, useful as antioxidizing pharmaceutical products having mucoregulating and anti-ischemic properties |
| 05/14/1992 | WO1992004024A3 Toxic agent protective compounds, compositions and method |
| 05/08/1992 | WO1992008707A1 Chelating agents |
| 05/08/1992 | CA2095727A1 Chelating agents |
| 05/06/1992 | EP0483634A2 An aminoglycoside composition having substantially reduced nephrotoxicity induced by the amino glycoside |
| 04/29/1992 | EP0482133A1 Use of lactoferrin to counter the toxic effects of endotoxins. |
| 04/28/1992 | US5108996 Antiinflammatory agents |
| 04/22/1992 | EP0481526A1 Chelants |
| 04/09/1992 | WO1992006094A1 Certain cycloalkyl and azacycloalkyl pyrrolopyrimidines; a new class of gaba brain receptor ligands |
| 03/25/1992 | CN1015982B Novel bicyclic lactam pharmacologically active compositions thereof process for the preparation thereof and their medical use |
| 03/10/1992 | US5095015 G-aminobutyric acid, anticonvulsants, tranquilizers, sleep disorders |
| 03/05/1992 | WO1992003535A1 Recombinant bpi proteins, uses of bpi proteins, and methods of preparing same |
| 03/05/1992 | WO1992003467A1 Transferrin binding proteins from neisseria gonorrhoeae and neisseria meningitidis |
| 03/01/1992 | WO1992004024A2 Toxic agent protective compounds, compositions and method |
| 03/01/1992 | CA2089158A1 Toxic agent protective compounds, compositions and method |
| 02/14/1992 | CA2088496A1 Recombinant bpi proteins, uses of bpi proteins, and methods of preparing same |
| 02/11/1992 | US5087743 Treatment of skin disorders |
| 02/05/1992 | CN1058337A Tablet and granulate containing sodium 2-mercaptoethanesulfonate |
| 02/04/1992 | WO1992004895A1 Enhancement of glutathione levels with glutamine |
| 01/29/1992 | EP0468245A1 Tablet and granulate containing MESNA as active agent |
| 01/23/1992 | DE4122167A1 Neutral tasting tablets and granules contg. Mesna - contain binder, disintegrating agent, lubricant filler and opt. effervescent mixt. |
| 01/14/1992 | US5081148 Blocking agents of edrf effect or formation for the treatment of shock |
| 01/14/1992 | US5081113 Novel 3-keto-steroids |
| 01/08/1992 | EP0464521A2 Polysulfide compounds and lipid peroxidation inhibitor containing the polysulfide compounds as active ingredient |
| 01/07/1992 | US5079234 Inhibitors of aminoglycoside nephrotoxicity |
| 01/02/1992 | EP0463123A1 1,4,10,13-tetraoxa-7,16-diazacyclooctadecane derivatives, pharmaceutical compositions containing them and their use for the removal of toxic metal ions and radioactive isotopes from the living organism |